Cohort of Patients Suffering From Major Depressive Episode With Evaluation of Sleep, Circadian Rhythms and Psychiatric Disorders
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · May 10, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how sleep patterns and biological rhythms affect people suffering from major depressive episodes. Researchers want to better understand the different ways depression can show up in patients, which could help in finding better ways to diagnose and treat this condition. The study is part of a larger effort in France to create a national group of patients, allowing scientists to identify specific markers related to sleep and mood disorders that could lead to more effective treatments.
If you or someone you know is experiencing a major depressive episode and meets certain criteria, you might be eligible to participate in this study. Eligible participants include both adults and children who can understand and read French, and who are willing to share their experiences through questionnaires. Participants can expect to be part of a nationwide effort to improve mental health care, and they will be contributing valuable information that could help others in the future. It’s important to note that individuals in emergency medical situations or those unable to provide informed consent won’t be able to take part in the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals with depressive episode characterized according to the DSM-5 criteria regardless of the associated characteristics and comorbidities.
- • Adult and child
- • Affiliated to a social security
- Exclusion Criteria:
- • don't understand or read french
- • Medical condition incompatible with administration of questionnaire
- • impossibility to give informed decision (subject in an emergency condition, etc.)
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported